IGF2BP1 and colorectal carcinoma: The ROC curve showed that IGF2BP1 expression may be a predictor of CRC tumorigenesis (Fig. S5E) and increased IGF2BP1 expression is associated with poor survival in CRC patients (Fig. 4L).